
Loading, please wait...

Loading, please wait...

A proactive **India Cancer Prevention** strategy offers the best opportunity to curb the nation’s rising cancer burden. The current reliance on treatment alone is insufficient, a sentiment strongly voiced by Dr. Pankaj Chaturvedi, Director of ACTREC, Tata Memorial Centre. Clinicians in India estimate that prevention holds a far greater impact than international studies suggest, potentially averting up to 70 per cent of cases for certain high-prevalence cancers like oral and breast cancer. Prevention, therefore, is an inevitable call to action to protect the population from late-stage interventions.
India is seeing a rapid expansion of hospital infrastructure across the country. However, patient waiting lists continue to grow, underscoring the fact that infrastructure alone cannot curb the mounting cancer burden. Dr. Chaturvedi argues that while most patients now possess some form of insurance coverage, cancers like oral, cervical, and breast cancer are largely preventable, unlike chronic conditions such as diabetes or hypertension. Consequently, early intervention and awareness are significantly more critical. The primary focus must shift from a relentless pursuit of treatment to advancing a comprehensive preventive strategy. Furthermore, integrating cancer prevention and control into the primary healthcare system is considered the most appropriate and cost-effective strategy for the Indian context.
Prevention finds its strongest footing in India because the most prevalent cancers—oral and breast—are highly responsive to early detection strategies. For instance, oral cancer typically takes between 10 to 15 years to develop, offering a wide window for prevention or early detection. Similarly, a study led by Dr. Chaturvedi in Dharavi, Mumbai, successfully demonstrated that mass breast cancer screening among women reduced mortality by a notable 30 per cent. Yet, fear of diagnosis remains a major barrier. Despite numerous government-run screening programmes nationwide, the uptake remains dismally low, hovering at around just 3 per cent.
To bridge the vast gap in screening uptake, Dr. Chaturvedi stressed the crucial importance of integrating technology. This includes implementing mobile-based screening tools to detect cancer at a reversible stage, especially in low-resource settings. At the Tata Memorial Centre, screening initiatives have shown a 93 per cent concurrence rate across 40,000 patients. Consequently, the institute is now developing advanced AI-based tools to further reduce the diagnostic burden on physicians. Moreover, the National Programme for Prevention and Control of Non-Communicable Diseases (NCD) is expanding its services, advocating for nationwide screening programs, and increasing accessibility to services for early detection.
Beyond institutional and technological interventions, sustainable impact hinges on fundamental lifestyle changes. Clinicians emphasise that addressing tobacco, alcohol, and areca nut consumption is essential, as these are major cancer risk factors and drivers of other non-communicable diseases. Additionally, oral hygiene is equally critical, playing a significant role in preventing oral cancers. While tobacco use is declining across generations, Dr. Chaturvedi cautioned that a sharp rise in alcohol consumption could keep the cancer burden elevated. Alcohol metabolises into acetaldehyde, a banned substance in India, which damages DNA and demonstrably increases cancer risk. Ultimately, shifting decisively towards prevention and early detection is no longer optional; it is an inevitable step to reverse India's rising cancer burden.
Q1: What is the estimated preventability of common Indian cancers?
Indian clinicians estimate that prevention could avert up to 70 per cent of cases for highly prevalent cancers like oral and breast cancer.
Q2: What is the main barrier to successful cancer screening in India?
The major barrier is the fear of diagnosis, which has resulted in a dismally low uptake of government-run screening programmes, currently around just 3 per cent.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Dr. Pankaj Chaturvedi stresses prevention over treatment to curb India's cancer burden, noting oral and breast cancers are highly preventable through early ...
7 months ago

A clinical comparison of extravascular and subcutaneous implantable cardioverter-defibrillators, detailing patient selection, pacing capabilities, and implantation nuances.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today